> top > docs > PubMed:33012653 > annotations

PubMed:33012653 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 981-994 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 0-8 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 35-48 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T3 93-103 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T4 109-156 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T5 109-142 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T6 158-166 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T7 247-256 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T8 277-301 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T9 303-311 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 408-416 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 443-456 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T12 502-515 Disease denotes infections in http://purl.obolibrary.org/obo/MONDO_0005550
T13 530-538 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 603-611 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 640-675 Disease denotes Acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T16 646-675 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T17 889-911 Disease denotes invasive aspergillosis http://purl.obolibrary.org/obo/MONDO_0000240
T18 898-911 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T19 1128-1137 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T20 1141-1149 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 1306-1319 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T22 1526-1534 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T23 1649-1662 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T24 1682-1690 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 1753-1761 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 50-51 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 84-89 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T3 803-809 http://purl.obolibrary.org/obo/CLO_0007926 denotes n = 22
T4 837-839 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T5 995-999 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 596-599 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T3 981-994 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T4 1201-1213 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T5 1288-1304 Chemical denotes antifungal agent http://purl.obolibrary.org/obo/CHEBI_35718
T6 1330-1335 Chemical denotes azole http://purl.obolibrary.org/obo/CHEBI_68452
T7 1390-1402 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T8 1458-1462 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T9 1463-1467 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 0-8 Disease denotes COVID-19 MESH:C000657245
3 25-48 Disease denotes pulmonary aspergillosis MESH:D055732
40 84-103 Disease denotes virus co-infections MESH:D060085
41 109-156 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
42 158-168 Species denotes SARS-CoV-2 Tax:2697049
43 232-243 Species denotes Aspergillus Tax:746128
44 247-256 Disease denotes infection MESH:D007239
45 263-271 Species denotes patients Tax:9606
46 277-301 Disease denotes coronavirus disease 2019 MESH:C000657245
47 303-311 Disease denotes COVID-19 MESH:C000657245
48 408-416 Disease denotes COVID-19 MESH:C000657245
49 433-456 Disease denotes pulmonary aspergillosis MESH:D055732
50 472-483 Species denotes Aspergillus Tax:746128
51 499-512 Disease denotes co-infections MESH:D060085
52 516-524 Species denotes patients Tax:9606
53 530-538 Disease denotes COVID-19 MESH:C000657245
54 603-611 Disease denotes COVID-19 MESH:C000657245
55 640-675 Disease denotes Acute respiratory distress syndrome MESH:D012128
56 755-764 Disease denotes mortality MESH:D003643
57 889-911 Disease denotes invasive aspergillosis MESH:D055744
58 981-994 Chemical denotes galactomannan MESH:C012990
59 1067-1088 Species denotes Aspergillus fumigatus Tax:746128
60 1128-1137 Disease denotes infection MESH:D007239
61 1141-1149 Disease denotes COVID-19 MESH:C000657245
62 1150-1158 Species denotes patients Tax:9606
63 1172-1190 Species denotes Aspergillus flavus Tax:5059
64 1201-1213 Chemical denotes voriconazole MESH:D065819
65 1238-1249 Species denotes Aspergillus Tax:746128
66 1306-1319 Disease denotes aspergillosis MESH:D001228
67 1330-1335 Chemical denotes azole MESH:D001393
68 1346-1357 Species denotes Aspergillus Tax:746128
69 1390-1402 Chemical denotes voriconazole MESH:D065819
70 1494-1517 Disease denotes cardiovascular toxicity MESH:D002318
71 1526-1536 Species denotes SARS-CoV-2 Tax:2697049
72 1639-1662 Disease denotes pulmonary aspergillosis MESH:D055732
73 1682-1690 Disease denotes COVID-19 MESH:C000657245
74 1691-1699 Species denotes patients Tax:9606
75 1753-1763 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 981-994 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 646-666 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-49 Sentence denotes COVID-19 associated with pulmonary aspergillosis:
T2 50-70 Sentence denotes A literature review.
T3 71-325 Sentence denotes Bacterial or virus co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in many studies, however, the knowledge on Aspergillus co-infection among patients with coronavirus disease 2019 (COVID-19) was limited.
T4 326-457 Sentence denotes This literature review aims to explore and describe the updated information about COVID-19 associated with pulmonary aspergillosis.
T5 458-578 Sentence denotes We found that Aspergillus spp. can cause co-infections in patients with COVID-19, especially in severe/critical illness.
T6 579-639 Sentence denotes The incidence of IPA in COVID-19 ranged from 19.6% to 33.3%.
T7 640-855 Sentence denotes Acute respiratory distress syndrome requiring mechanical ventilation was the common complications, and the overall mortality was high, which could be up to 64.7% (n = 22) in the pooled analysis of 34 reported cases.
T8 856-961 Sentence denotes The conventional risk factors of invasive aspergillosis were not common among these specific populations.
T9 962-1066 Sentence denotes Fungus culture and galactomannan test, especially from respiratory specimens could help early diagnosis.
T10 1067-1191 Sentence denotes Aspergillus fumigatus was the most common species causing co-infection in COVID-19 patients, followed by Aspergillus flavus.
T11 1192-1375 Sentence denotes Although voriconazole is the recommended anti-Aspergillus agent and also the most commonly used antifungal agent, aspergillosis caused by azole-resistant Aspergillus is also possible.
T12 1376-1544 Sentence denotes Additionally, voriconazole should be used carefully in the concern of complicated drug-drug interaction and enhancing cardiovascular toxicity on anti-SARS-CoV-2 agents.
T13 1545-1810 Sentence denotes Finally, this review suggests that clinicians should keep alerting the possible occurrence of pulmonary aspergillosis in severe/critical COVID-19 patients, and aggressively microbiologic study in addition to SARS-CoV-2 via respiratory specimens should be indicated.